HBV Quantitative

During diagnosis of blood-borne infections, PCR technology has a great importance especially in blood banking and to detection very early infections before antibodies have been developed..

PCR technology solves the following blood banking tasks:

• Ensuring infection safety during the period of “seronegative window”;

• Providing information that no infectious agents were found in the blood or blood components with ambiguous results of enzyme multiplied immunoassay obtained;

• Identifying true virus carriers among seropositive individuals.

The HBV Quantitative REAL-TIME PCR Kit is intended for research and diagnostic applications as well as for evaluation of the therapy efficiency. The HBV Quantitative REAL-TIME PCR Kit is an in vitro Nucleic Acid Test (NAT) – based on pathogen detection and calculation of viral load.

The HBV Quantitative REAL-TIME PCR Kit is designed to detect and calculate the viral load of Hepatitis B Virus (HBV) nucleic acids in human blood plasma samples with an aid of Quantitative Real-Time Polymerase Chain Reaction (qPCR) method.

The HBV Quantitative REAL-TIME PCR Kit can be used in clinical practice for HBV diagnostics.

Analytical specificity: the HBV Quantitative Real-Time PCR Kit allows detection of all known HBV subtypes. The samples containing HBV will be defined as positive and characterized quantitatively. The samples not containing HBV will be defined as negative.

Sensitivity: not less than 200 copies of HBV DNA per 1 mL of blood plasma.

Certification: RU/IVD